Anna Ehinger
31 – 40 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers into breast cancer clinical trials and daily practice
- Contribution to journal › Scientific review
-
Mark
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
(2020) UK Interdisciplinary Breast Cancer Symposium 2020 In Breast Cancer Research and Treatment 180. p.531-532
- Contribution to journal › Published meeting abstract
-
Mark
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
- Contribution to journal › Article
-
Mark
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
- Contribution to journal › Article
-
Mark
Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).
- Contribution to journal › Published meeting abstract
-
Mark
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
- Contribution to journal › Article
-
Mark
Spatial Deconvolution of HER2-positive Breast Tumors Reveals Novel Intercellular Relationships
(2020)
- Other contribution › Miscellaneous
-
Mark
The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome
(2020)
- Working paper/Preprint › Preprint in preprint archive
- 2019
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
- Contribution to journal › Article
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
- Contribution to journal › Article
